Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions

International Journal of Gynecological Pathology

Volumn 26, Issue 4, 2007, Pages 387-394

  Emerson, Robert E ^a   Wang, Mingsheng ^a   Liu, Fang ^b   Lawrence, W Dwayne ^b   Abdul Karim, Fadi W ^c   Cheng, Liang ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Clonality; Low malignant potential; Lymph node inclusions; Ovary; Peritoneal implants

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMPLANT; LYMPH NODE; MALIGNANT NEOPLASTIC DISEASE; MICRODISSECTION; MOLECULAR GENETICS; OVARY TUMOR; PERITONEUM; PRIORITY JOURNAL; SEROSA; X CHROMATIN;

ADOLESCENT; ADULT; AGED; CYSTADENOMA, SEROUS; DNA, NEOPLASM; FEMALE; HUMANS; LASERS; LYMPH NODES; LYMPHATIC METASTASIS; MICRODISSECTION; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; POLYMERASE CHAIN REACTION; X CHROMOSOME INACTIVATION;

EID: 34748862395     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/pgp.0b013e3180336287     Document Type: Article

References (40)

1. Seidman J, Russell P, Kurman R. Surface epithelial tumors of the ovary. In: Kurman R, ed. Blaustein's Pathology of the Female Genital Tract, 5th ed. New York, NY: Springer-Verlag, 2002:791-905.
2. Leake J, Currie J, Rosenshein N, et al. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992;47:150-8.
3. Leake J, Rader J, Woodruff J, et al. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991;42:124-30.
4. McKenney J, Balzer B, Longacre T. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification. Am J Surg Pathol 2006;30:614-24.
5. Kennedy A, Hart W. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): a long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 1996;78:278-86.
6. Longacre T, McKenney J, Tazelaar H, et al. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol 2005;29:707-23.
7. Seidman J, Kurman R. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:539-57.
8. Bostwick D, Tazelaar H, Ballon S, et al. Ovarian epithelial tumor of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer 1986;58:2052-65.
9. Bell D, Weinstock M, Scully R. Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis. Cancer 1988;62:2212-22.
10. Nishimura N, Hachisuga T, Nabeshima K, et al. Synchronous endometrial and ovarian carcinomas: analysis of genetic relationship of the tumors. Int J Oncol 2005;27:1519-26.
11. Brinkmann D, Ryan A, Ayhan A, et al. A molecular genetic and statistical approach for the diagnosis of dual-site cancers. J Natl Cancer Inst 2004;96:1441-6.
12. Fujii H, Matsumoto T, Yoshida M, et al. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability. Hum Pathol 2002;33:421-8.
13. Emmert-Buck M, Chuaqui R, Zhuang Z, et al. Molecular analysis of synchronous uterine and ovarian endometrioid tumors. Int J Gynecol Pathol 1997;16:143-8.
14. Shenson D, Gallion H, Powell D, et al. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer 1995;76:650-7.
15. Feltmate C, Lee K, Johnson M, et al. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Clin Cancer Res 2005;11:7651-7.
16. Szych C, Staebler A, Connolly D, et al. Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol 1999;155:1849-55.
17. Chuaqui R, Zhaung Z, Emmert-Buck M, et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol 1996;27:165-71.
18. Muto M, Welch W, Mok S, et al. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res 1995;55:490-2.
19. Krishnamurti U, Sasatomi E, Swalsky P, et al. Microdissection-based mutational genotyping of serous borderline tumors of the ovary. Int J Gynecol Pathol 2004;24:56-61.
20. Gu J, Roth L, Younger C, et al. Molecular genetic evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst 2001;93:1147-52.
21. Sieben N, Kolkman-Uljee S, Flanagan A, et al. Molecular genetic evidence for monoclonal origin for bilateral ovarian serous borderline tumors. Am J Pathol 2003;162:1095-101.
22. Allen R, Zoghbi H, Moseley A, et al. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992;51:1229-39.
23. Tilley W, Marcelli M, Wilson J, et al. Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci U S A 1989;86:327-31.
24. Jiang X, Morland S, Hitchcock A, et al. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res 1998;58:1707-12.
25. Li S, Han H, Resnik E, et al. Advanced ovarian carcinoma: molecular genetic evidence of unifocal origin. Gynecol Oncol 1993;51:21-5.
26. Jacobs I, Kohler M, Wiseman R, et al. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J Natl Cancer Inst 1992;84:1793-8.
27. Buller R, Skilling J, Sood A, et al. Field cancerization: why late "recurrent" ovarian cancer is not recurrent. Am J Obstet Gynecol 1998;178:641-9.
28. Schorge J, Muto M, Welch W, et al. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst 1998;90:841-5.
29. Lu K, Bell D, Welch W, et al. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res 1998;58:2328-30.
30. Kernek K, Ulbright T, Zhang S, et al. Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis. Am J Pathol 2003;163:2477-84.
31. Brandli D, Ulbright T, Foster R, et al. Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma. Cancer Res 2003;63:6063-8.
32. McCarthy R, Zhang S, Bostwick D, et al. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. Am J Pathol 2004;165:1395-400.
33. Cheng L, MacLennan G, Zhang S, et al. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer 2004;101:183-8.
34. Cheng L, Gu J, Ulbright T, et al. Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor. Cancer 2002;94:104-10.
35. Rollins S, Young R, Bell D. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Am J Surg Pathol 2006;30:457-62.
36. Shiraki M, Otis C, Donovan J, et al. Ovarian serous borderline epithelial tumors with multiple retroperitoneal nodal involvement: metastasis or malignant transformation of epithelial glandular inclusions? Gynecol Oncol 1992;46:255-8.
37. Kadar N, Krumerman M. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor). Gynecol Oncol 1994;59:394-7.
38. Tan L, Flynn S, Carcangiu M. Ovarian serous borderline tumors with lymph node involvement: clinicopathologic and DNA content study of seven cases and review of the literature. Am J Surg Pathol 1994;18:904-12.
39. Moore W, Bentley R, Berchuck A, et al. Some mullerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumors of the ovary. Am J Surg Pathol 2000;24:710-8.
40. Matias-Guiu X, Lagarda H, Catasus L, et al. Clonality analysis in synchronous or metachronous tumors of the female genital tract. Int J Gynecol Pathol 2002;21:205-11.